Firefighters exposed to toxic dust and fumes clogging the air after the World Trade Center towers collapsed 10 years ago are more likely to develop cancer, according to a new study.
Former vice presidential candidate Geraldine Ferraro, who died on Saturday at age 75 of the incurable blood cancer called multiple myeloma, and Richard J. "Rick" Corman, 55, whom FORTUNE profiled in its March 21 issue, knew each other because they had met at Dana-Farber Cancer Institute in Boston, where both were fighting this killer disease. They in fact had the same set of doctors, Kenneth Anderson, director of the institute's multiple-myeloma practice, and his colleague, Paul Richardson.
CNN's Deborah Feyerick has the story of a 9/11 first responder who's fighting for his life.
Firefighter Randy Wiebicke who, like so many New York City firefighters, toiled in and around ground zero in the months after 9/11, died Wednesday following a nearly three-year battle with multiple myeloma, an aggressive and fatal blood cancer.
To watch Dale Webster in the movie, Step Into Liquid, go here. Webster's cameo starts at the 19:33 mark.
Roy Scheider, a two-time Oscar nominee who played the alarmist police chief who famously saves a beach resort in the 1975 blockbuster Jaws and its sequel, died Sunday. He was 75.
Appreciation: Folkman, who died Monday, cured cancer in the lab and revolutionized treatment of the disease. His colleagues talk about the impact of the man and his research
The market for blood cancer treatment is heating up. And that could result in a David versus Goliath face-off, or a potentially potent partnership.
Celgene, the drug company that's cornered the market for blood cancer treatment, continues to wow investors with its constantly climbing stock price, and analysts expect the good times to keep rolling.
The FDA approved a drug combo from Celgene that slows the spread of blood cancer, the biotech said, which could help push the treatment to blockbuster status.
Thalomid, formerly the bane of the pharmaceutical industry as a dangerous pregnancy painkiller, has gotten a second life and could help fast-growing Celgene corner the market as a blood cancer treatment.
Celgene, the fastest-growing tech company in the pharmaceutical industry, owes much of its success to a drug that was once the bane of the pharmaceutical industry.
On the heels of disappointing results for thalidomide as a treatment for bone marrow cancer, a smaller study suggests the drug may prolong survival of elderly patients, but at a price.
Denise Villani was told she had a cancer that could not be cured, but three and a half years on, after taking part in a clinical trial for a vaccine, she is cancer-free. This is her story:
NEW YORK (CNN/Money) - The notion of "rich" is frequent fodder for headlines. In the past month alone we've learned:
Geraldine Ferraro, the first and only woman nominated to the presidential ticket of a major U.S. political party, remains an inspiration to women aspiring to success in all walks of life.
Geraldine Ferraro, the first and only woman nominated to the presidential ticket of a major U.S. political party, remains an inspiration to women aspiring to success in all walks of life.
Stocks closed little changed Friday at the end of a shortened post-holiday session.
BIOTECHNOLOGY still generates more headlines than profits, and no major drug company knows that better than Schering-Plough. It made one of the earliest and costliest bets on the science -- and has...
© 2013 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
|